Cannabidivarinic Acid, commonly abbreviated as CBDVA, is a non-psychoactive cannabinoid found in the Cannabis sativa plant. It is a homolog of cannabidiolic acid (CBDA), with a propyl side chain rather than the pentyl side chain found in CBDA. CBDVA is one of the many cannabinoids that occur naturally in hemp and cannabis, albeit typically in lower concentrations compared to more prominent compounds such as tetrahydrocannabinol (THC) and cannabidiol (CBD). As an acidic precursor to cannabidivarin (CBDV), it undergoes decarboxylation, a chemical reaction that releases carbon dioxide, when exposed to heat or sunlight, converting it into CBDV. This process is similar to the conversion of CBDA into CBD. The potential therapeutic benefits of CBDVA are still under investigation, but early research suggests that it may have applications in the treatment of a variety of conditions, including neurological disorders and inflammation. As with other cannabinoids, CBDVA is thought to interact with the endocannabinoid system in the human body, which plays a role in regulating a wide array of physiological processes. The pharmacological profile of CBDVA, like that of many minor cannabinoids, remains less well-characterized than that of major cannabinoids, but ongoing research continues to explore its properties and potential medical applications.
YOU MUST BE 21 YEARS OF AGE OR OLDER TO VIEW OR SUBMIT INFORMATION TO HEMPONIX.COM
FDA DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.